Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safinamide as add-on therapy to levodopa in idiopathic Parkinson's disease with motor fluctuations; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Safinamide (Safinamide)

Snippet

Sponsor: Zambon SpA | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-03-20